Is the loss of thalamostriatal neurons protective in parkinsonism?

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3(Suppl 3):S162-6. doi: 10.1016/S1353-8020(09)70806-5.

Abstract

Neuronal loss in Parkinson's disease (PD) is more widespread than originally thought. Among the extrastriatal sites in which significant loss of neurons has been reported is the centremedian-parafascicular (CM-PF) complex of the thalamus, which provides one of the three major afferent sources to the striatum. The functional significance of CM-PF loss in PD is unclear. Interestingly, several recent small trials have suggested that deep brain stimulation of the CM-PF improves motor function in PD. We discuss the possible transsynaptic determination of CM-PF loss secondary to nigrostriatal dopamine degeneration, and suggest that expression of the glycoprotein cerebellin1 (Cbln1) in CM-PF neurons may play an important role in striatal synaptic remodeling in parkinsonism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Death / physiology
  • Corpus Striatum / pathology*
  • Dopamine / metabolism
  • Humans
  • Nerve Degeneration / etiology
  • Nerve Degeneration / pathology*
  • Nerve Tissue Proteins / metabolism
  • Neural Pathways / pathology
  • Parkinson Disease / complications
  • Parkinson Disease / pathology
  • Parkinson Disease / prevention & control*
  • Protein Precursors / metabolism
  • Synapses / pathology
  • Thalamus / pathology*

Substances

  • CBLN1 protein, human
  • Nerve Tissue Proteins
  • Protein Precursors
  • Dopamine